 Oxford Vaccine Group logo | |
| Formation | 1994 |
|---|---|
| Purpose | Research and clinical trials |
| Location |
|
Director | Professor Andrew J Pollard |
Parent organization | University of Oxford |
| Affiliations | UKCRC registered |
| Staff | 75 |
| Website | www |
The Oxford Vaccine Group (OVG) is a vaccine research group within the Department of Paediatrics at the University of Oxford. It was founded in 1994 by Professor E. Richard Moxon, was initially based at the John Radcliffe Hospital, and moved in 2003 to its current location in the Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) at the Churchill Hospital in Oxford, England.[1] The group, led by Professor Andrew Pollard since 2001, comprises around 75 members across a number of disciplines, including consultants in paediatrics and vaccinology, clinical research fellows, research nurses, statisticians, post-doctoral laboratory scientists, research assistants and DPhil students.
OVG came to public prominence in 2020 for the vaccine it created to combat COVID-19.
- ^ "Oxford Vaccine Group website. Retrieved 25 June 2015". Archived from the original on 17 September 2016. Retrieved 7 November 2012.